MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 130535 | Name: BCCov

Description:

WARNING: This product is for research use only, not for human or veterinary use.

BCCov is a novel irreversible covalent Bruton's tyrosine kinase (BTK) degrader, which is critical for proliferation and survival of leukemic cells. BCCov modifies BTK in cells and drives a distinct ternary complex structure.

Chemical Structure

BCCov
BCCov
CAS#BCCov

Theoretical Analysis

MedKoo Cat#: 130535

Name: BCCov

CAS#: BCCov

Chemical Formula: C62H74N12O7

Exact Mass: 1098.5803

Molecular Weight: 1099.35

Elemental Analysis: C, 67.74; H, 6.79; N, 15.29; O, 10.19

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
BC-Cov, BC Cov, BTK cIAP1 Covalent degrader, BTK-cIAP1 Covalent degrader, BTK degrader
IUPAC/Chemical Name
BTK-cIAP1-Covalent degrader; (4R)-4-(2-(2-(4-((E)-4-((R)-3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)piperidin-1-yl)-4-oxobut-2-en-1-yl)piperazin-1-yl)ethoxy)acetamido)-1-((S)-2-((R)-2-(methylamino)propanamido)-2-phenylacetyl)-N-((S)-1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine-2-carboxamide
InChi Key
SSOWBCMITSWXKO-GNIFOPGYSA-N
InChi Code
InChI=1S/C62H74N12O7/c1-42(64-2)60(77)68-58(44-15-5-3-6-16-44)62(79)73-39-46(38-53(73)61(78)67-52-22-11-17-43-14-9-10-21-50(43)52)66-54(75)41-80-37-36-71-34-32-70(33-35-71)30-13-23-55(76)72-31-12-18-47(40-72)74-59-56(51(63)28-29-65-59)57(69-74)45-24-26-49(27-25-45)81-48-19-7-4-8-20-48/h3-10,13-16,19-21,23-29,42,46-47,52-53,58,64H,11-12,17-18,22,30-41H2,1-2H3,(H2,63,65)(H,66,75)(H,67,78)(H,68,77)/b23-13+/t42-,46-,47-,52+,53?,58+/m1/s1
SMILES Code
O=C(C1N(C([C@@H](NC([C@H](NC)C)=O)C2=CC=CC=C2)=O)C[C@H](NC(COCCN3CCN(C/C=C/C(N4C[C@H](N5N=C(C6=CC=C(OC7=CC=CC=C7)C=C6)C8=C(N)C=CN=C85)CCC4)=O)CC3)=O)C1)N[C@H]9CCCC%10=C9C=CC=C%10
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,099.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. Schiemer J, Maxwell A, Horst R, Liu S, Uccello DP, Borzilleri K, Rajamohan N, Brown MF, Calabrese MF. A covalent BTK ternary complex compatible with targeted protein degradation. Nat Commun. 2023 Mar 2;14(1):1189. doi: 10.1038/s41467-023-36738-z. PMID: 36864023; PMCID: PMC9981747.